Arbovirus Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (ELISA-based Tests, RT-PCR based Tests, and Others); By Arboviral Disease; By End-use; By Region; Segment Forecast, 2024- 2032

Arbovirus Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (ELISA-based Tests, RT-PCR based Tests, and Others); By Arboviral Disease; By End-use; By Region; Segment Forecast, 2024- 2032

The global arbovirus testing market size is expected to reach USD 2.24 billion by 2032, according to a new study by Polaris Market Research. The report “Arbovirus Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (ELISA-based Tests, RT-PCR based Tests, and Others); By Arboviral Disease; By End-use; By Region; Segment Forecast, 2024- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The primary drivers propelling the growth of the arbovirus testing market are the rising number of patients infected with arthropod-borne viral infections and the growing number of government programs aimed at controlling the burden of arboviral diseases. For instance, according to the data from the European Centre for Disease Prevention and Control, in 2023, the number of chikungunya cases in Brazil and Paraguay were 256,927 and 140,905, respectively. Moreover, the growing cases of West Nile Virus infections in countries such as the U.S., coupled with an increased focus on government activities to promote the advantages of early testing, are expected to boost the market growth in the upcoming years.

The increased risk of arboviral diseases that people of tropical and subtropical regions experience due to warm temperatures and high humidity will be beneficial for the market expansion. Moreover, the high priority of governments on funding, allocation of resources, and establishment of programs for managing the burden of arboviral diseases drives market growth. Furthermore, rising cases of yellow fever, dengue, and chikungunya in developing countries contribute to market growth. For instance, according to the European Centre for Disease Prevention and Control’s data, in 2023, the number of chikungunya cases in the Philippines was 2,561. Such a large patient pool from developing countries will provide an opportunity for the growth of the arbovirus testing market during the forecast timeframe.

The main causes for the rising incidence of arboviral infections include urbanization, climate change, and greater travel of people and goods. Moreover, the climatic changes leading to high temperatures and humidity increase the risk of spread of the dengue epidemic, thereby fueling the demand for arbovirus tests. Furthermore, market players prioritizing the introduction of new products coupled with a rise in research and development expenditures for rapid tests are expected to foster the arbovirus testing market growth in the projected years.

Arbovirus Testing Market Report Highlights

The ELISA-based tests segment dominated the market, owing to the innovation, continuous improvements, and technological advancements associated with the test.

The dengue segment accounted for a considerable market share, owing to the growing number of dengue cases and mortalities worldwide.

The public health laboratories segment accounted for the largest market share, owing to government initiatives and rising funding for diagnostic testing of diseases.

North America dominated the arbovirus testing market, owing to the presence of a large patient pool for arboviral diseases coupled with the high testing volume.

The market players include Agilent Technologies Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, Abbott, etc.

Polaris Market Research has segmented the arbovirus testing market report based on test type, arboviral disease, end-use, and region:

Arbovirus Testing, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

ELISA-based Tests

RT-PCR based Tests

Others

Arbovirus Testing, Arboviral Disease Outlook (Revenue - USD Billion, 2019 - 2032)

Dengue

Yellow Fever

Zika Virus

West Nile Virus

Chikungunya

Others

Arbovirus Testing, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals

Diagnostic Centers

Public Health Laboratories

Others

Arbovirus Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Australia

Malaysia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa